JIP
BIIB icon

Jaffetilchin Investment Partners’s Biogen BIIB Stock Holding History

Jaffetilchin Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-239
Closed -$46.3K – 468
2024
Q3 		$46.3K Buy
+239
New +$50K ﹤0.01% 598
2016
Q4 		– Sell
-2,278
Closed -$713K – 247
2016
Q3 		$713K Buy
+2,278
New +$675K 0.23% 69
2015
Q2 		– Sell
-2,643
Closed -$1.12M – 201
2015
Q1 		$1.12M Buy
2,643
+1,326
+101% +$523K 0.34% 44
2014
Q4 		$447K Buy
1,317
+72
+6% +$23.3K 0.15% 97
2014
Q3 		$412K Buy
+1,245
New +$411K 0.15% 106
2014
Q2 		– Sell
-2,477
Closed -$758K – 204
2014
Q1 		$758K Sell
2,477
-299
-11% -$94.9K 0.3% 52
2013
Q4 		$776K Sell
2,776
-1,668
-38% -$431K 0.38% 59
2013
Q3 		$1.07M Buy
4,444
+1,287
+41% +$288K 0.63% 36
2013
Q2 		$679K Buy
+3,157
New +$675K 0.47% 52

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jaffetilchin Investment Partners's BIIB Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Biogen (BIIB) in Q4 2024, closing a stake of 239 shares — an estimated $46.3K sold.

Jaffetilchin Investment Partners first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $1.12M in Q1 2015. 875 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 239 Biogen shares in Q4 2024, an estimated $46.3K.
  • Jaffetilchin Investment Partners first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • Jaffetilchin Investment Partners's Biogen position peaked at $1.12M in Q1 2015.
  • 875 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.